JP2018504903A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018504903A5 JP2018504903A5 JP2017537906A JP2017537906A JP2018504903A5 JP 2018504903 A5 JP2018504903 A5 JP 2018504903A5 JP 2017537906 A JP2017537906 A JP 2017537906A JP 2017537906 A JP2017537906 A JP 2017537906A JP 2018504903 A5 JP2018504903 A5 JP 2018504903A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- epitope
- segment
- amino acid
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/AU2015/000019 WO2016112423A1 (en) | 2015-01-16 | 2015-01-16 | Glypican epitopes and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020093553A Division JP7053058B2 (ja) | 2020-05-28 | 2020-05-28 | グリピカンエピトープおよびその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018504903A JP2018504903A (ja) | 2018-02-22 |
| JP2018504903A5 true JP2018504903A5 (enExample) | 2018-04-05 |
| JP6735005B2 JP6735005B2 (ja) | 2020-08-05 |
Family
ID=56405046
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017537906A Active JP6735005B2 (ja) | 2015-01-16 | 2015-01-16 | グリピカンエピトープおよびその使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US20180002391A1 (enExample) |
| EP (1) | EP3245219B1 (enExample) |
| JP (1) | JP6735005B2 (enExample) |
| KR (1) | KR102435383B1 (enExample) |
| CN (1) | CN107531755B (enExample) |
| AU (1) | AU2015376851B2 (enExample) |
| CA (1) | CA2973771A1 (enExample) |
| DK (1) | DK3245219T3 (enExample) |
| ES (1) | ES2805085T3 (enExample) |
| SG (1) | SG11201705808XA (enExample) |
| WO (1) | WO2016112423A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3209686T3 (da) | 2014-10-23 | 2020-03-16 | Glyp Holdings Pty Ltd | Monoklonale anti-gpc-1-antistoffer og anvendelser deraf |
| US11198738B2 (en) | 2015-04-20 | 2021-12-14 | Minomic International Ltd. | Therapeutic antibodies and uses thereof |
| US20200308299A1 (en) * | 2017-04-28 | 2020-10-01 | National University Corporation Kochi University | Anti-gpc-1 antibody |
| CN113784987B (zh) * | 2019-01-22 | 2024-09-13 | 美国政府(由卫生和人类服务部的部长所代表) | 靶向磷脂酰肌醇蛋白聚糖-1的高亲和力单克隆抗体和使用方法 |
| CN111187350A (zh) * | 2019-12-30 | 2020-05-22 | 西安英创生物技术有限公司 | 一种与磷脂酰肌醇蛋白聚糖-1结合的抗原结合蛋白 |
| IT202200021546A1 (it) | 2022-10-19 | 2024-04-19 | Centro Di Riferimento Oncologico Di Aviano | Anticorpo monoclonale anti-GPC1, suoi usi terapeutici e diagnostici |
| WO2025202361A1 (en) * | 2024-03-27 | 2025-10-02 | Adcendo Aps | Anti-gpc1 antibodies and uses thereof |
| WO2025202359A1 (en) * | 2024-03-27 | 2025-10-02 | Adcendo Aps | Anti-gpc1 antibodies and uses thereof |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4356270A (en) | 1977-11-08 | 1982-10-26 | Genentech, Inc. | Recombinant DNA cloning vehicle |
| US4458066A (en) | 1980-02-29 | 1984-07-03 | University Patents, Inc. | Process for preparing polynucleotides |
| US4751180A (en) | 1985-03-28 | 1988-06-14 | Chiron Corporation | Expression using fused genes providing for protein product |
| US4935233A (en) | 1985-12-02 | 1990-06-19 | G. D. Searle And Company | Covalently linked polypeptide cell modulators |
| US5840839A (en) * | 1996-02-09 | 1998-11-24 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein |
| WO1999037764A2 (en) | 1998-01-27 | 1999-07-29 | Vlaams Interuniversitair Instituut Voor Biotechnologie | New members of the glypican gene family |
| CA2346264A1 (en) * | 1998-10-16 | 2000-04-27 | Regents Of The University Of California | Glypicans for the detection and treatment of human carcinoma |
| US20040226056A1 (en) * | 1998-12-22 | 2004-11-11 | Myriad Genetics, Incorporated | Compositions and methods for treating neurological disorders and diseases |
| ATE483801T1 (de) * | 2001-06-22 | 2010-10-15 | Chugai Pharmaceutical Co Ltd | Zellproliferationshemmer, die anti-glypican 3 antikörper enthalten |
| SI1674111T1 (sl) * | 2004-07-09 | 2011-02-28 | Chugai Pharmaceutical Co Ltd | Protitelo proti glipikanu 3 |
| US20070087005A1 (en) * | 2005-10-14 | 2007-04-19 | Lazar Gregory A | Anti-glypican-3 antibody |
| WO2010019250A2 (en) | 2008-08-11 | 2010-02-18 | Solarflare Communications, Inc. | Method of synchronization for low power idle |
| CN102180969B (zh) * | 2011-01-30 | 2013-04-10 | 中国人民解放军军事医学科学院微生物流行病研究所 | 抗肝癌活性单克隆抗体及其应用 |
-
2015
- 2015-01-16 EP EP15877381.2A patent/EP3245219B1/en active Active
- 2015-01-16 CN CN201580076839.6A patent/CN107531755B/zh active Active
- 2015-01-16 DK DK15877381.2T patent/DK3245219T3/da active
- 2015-01-16 ES ES15877381T patent/ES2805085T3/es active Active
- 2015-01-16 JP JP2017537906A patent/JP6735005B2/ja active Active
- 2015-01-16 US US15/543,877 patent/US20180002391A1/en not_active Abandoned
- 2015-01-16 CA CA2973771A patent/CA2973771A1/en active Pending
- 2015-01-16 SG SG11201705808XA patent/SG11201705808XA/en unknown
- 2015-01-16 KR KR1020177022547A patent/KR102435383B1/ko active Active
- 2015-01-16 AU AU2015376851A patent/AU2015376851B2/en active Active
- 2015-01-16 WO PCT/AU2015/000019 patent/WO2016112423A1/en not_active Ceased
-
2020
- 2020-07-27 US US16/939,729 patent/US20210107958A1/en not_active Abandoned
-
2023
- 2023-07-28 US US18/361,407 patent/US20240247037A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018504903A5 (enExample) | ||
| Fujii et al. | PA tag: a versatile protein tagging system using a super high affinity antibody against a dodecapeptide derived from human podoplanin | |
| WO2018057735A8 (en) | Antibodies for siglec-15 and methods of use thereof | |
| HK1207655A1 (en) | Affinity matured anti-ccr4 humanized monoclonal antibodies and methods of use | |
| EA201891066A1 (ru) | Антитела к ror1 | |
| JP2016029056A5 (enExample) | ||
| JOP20190248A1 (ar) | بروتينات ربط مولد ضد trem2 واستخداماته | |
| JP2017524725A5 (enExample) | ||
| JP2018042573A5 (enExample) | ||
| JP2017113004A5 (enExample) | ||
| JP2017520575A5 (enExample) | ||
| JP2017518366A5 (enExample) | ||
| JP2013060443A5 (enExample) | ||
| WO2017152102A3 (en) | Anti-trem1 antibodies and methods of use thereof | |
| JP2014221064A5 (enExample) | ||
| NZ615441A (en) | Humanised antibodies to toll-like receptor 2 and uses thereof | |
| HRP20130877T1 (hr) | Antitijela koja neutraliziraju humani citomegalovirus i njihova primjena | |
| HRP20192347T1 (hr) | Antitijela prema klaudinu 18.2 koja su korisna u dijagnozi tumora | |
| JP2016512214A5 (enExample) | ||
| HRP20200034T1 (hr) | Monoklonska protutijela protiv čimbenika rasta i diferencijacije 15 (gdf-15), te njihova upotreba u liječenju kaheksije uzrokovane rakom i raka | |
| JP2021500916A5 (enExample) | ||
| JP2018507254A5 (enExample) | ||
| CN105968201A (zh) | 针对前列腺特异性膜抗原的单域重链抗体 | |
| JP2017512825A5 (enExample) | ||
| JP2017529870A5 (enExample) |